Trials / Conditions / Congenital Abnormalities

Congenital Abnormalities

33 registered clinical trials studyying Congenital Abnormalities — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH NCT07166172	Johns Hopkins University	N/A
Recruiting	The Combined First Trimester Screening NCT07015203	Institute of Health Information and Statistics of the Czech Republic	—
Recruiting	A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis NCT06917690	Chiesi Farmaceutici S.p.A.	Phase 3
Recruiting	Effectiveness of a Psychosocial Support Intervention for Women Diagnosed With Fetal Anomaly NCT07084103	Sakarya University	N/A
Completed	3D Modeling of the Cervico-facial Region and Cranial Nerve Tractography: IMAG 2 ORL Project NCT05763615	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Safety and Effectiveness of a Virtual Pediatric Cardiac Rehabilitation Program or Telerehabilitation in Childr NCT06819059	Columbia University	N/A
Active Not Recruiting	Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) NCT05696444	Medtronic - MITG	N/A
Not Yet Recruiting	Evaluation of 3D Printed Myoelectric Prosthetic Devices in Children With Upper Congenital Limb Deficiency NCT05547308	Orlando Health, Inc.	N/A
Unknown	Congenital Anomalies in Infants of Diabetic Mother NCT05393167	Assiut University	—
Unknown	Pattern Recognition and Anomaly Detection in Fetal Morphology Using Deep Learning and Statistical Learning NCT05738954	University of Craiova	—
Unknown	Birth Defect Registry in South West Region of France NCT05231447	University Hospital, Bordeaux	—
Unknown	Digital Occlusal Wafer Versus Waferless Distal Segment Repositioning for BSSO in Skeletal Mandibular Deformiti NCT05151042	Cairo University	N/A
Recruiting	Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parent NCT05394363	Murdoch Childrens Research Institute	—
Completed	Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment NCT05883761	Elizabeth Glaser Pediatric AIDS Foundation	—
Active Not Recruiting	Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD NCT04591392	atHeart Medical	N/A
Completed	Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader NCT05657860	Maimonides Medical Center	Phase 4
Suspended	Exercise Training Strategies for Children With Repaired Tetralogy of Fallot NCT04208893	The Hospital for Sick Children	N/A
Unknown	Drug-induced Repolarization ECG Changes NCT03642405	Copenhagen University Hospital at Herlev	—
Completed	COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction NCT02987387	Edwards Lifesciences	—
Completed	'TOTAL' (Tracheal Occlusion To Accelerate Lung Growth) Trial NCT02875860	Michael A Belfort	Phase 2
Recruiting	Pregnancies Complicated by Fetal Anomalies NCT02505464	University of Tennessee	—
Completed	Apparently Balanced Chromosomal Translocation/ Next-generation Sequencing/ Intellectual Disability NCT02451761	Hospices Civils de Lyon	—
Terminated	Mitroflow DL Post Approval Study- North America NCT02351726	LivaNova	N/A
Unknown	Improving Informed Consent for Cleft Palate Repair NCT02595307	IWK Health Centre	N/A
Completed	NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing NCT01969370	University of North Carolina, Chapel Hill	N/A
Completed	An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients NCT02429947	University of South Florida	—
Completed	BioThrax® (Anthrax) Vaccine in Pregnancy Registry NCT01653392	Emergent BioSolutions	—
Completed	Clinical and Genetic Studies of VACTERL Association NCT00766571	National Human Genome Research Institute (NHGRI)	—
Completed	An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patie NCT00694109	Kastle Therapeutics, LLC	Phase 3
Completed	Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemi NCT00607373	Kastle Therapeutics, LLC	Phase 3
Completed	Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia NCT00477594	Kastle Therapeutics, LLC	Phase 2
Completed	Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration NCT00362180	Kastle Therapeutics, LLC	Phase 2
Completed	Esophageal Motility and Airway Defenses Among Infants NCT00062452	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	—